Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela L Zeitlin

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging drug treatments for cystic fibrosisPamela L Zeitlin
The Journal of Clinical Investigation|November 27, 2008
Cystic fibrosis and estrogens: a perfect stormPamela L Zeitlin
Molecular Pharmacology|August 1, 2006
Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?Pamela L Zeitlin
American Journal of Physiology. Cell Physiology|June 26, 2009
Pseudomonas aeruginosa: can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa"Pamela L Zeitlin
Expert Opinion on Emerging Drugs|July 3, 2007
Emerging drug treatments for cystic fibrosisPamela L Zeitlin
Advanced Drug Delivery Reviews|November 30, 2002
Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targetingKristina Powell, Pamela L Zeitlin
American Journal of Respiratory Cell and Molecular Biology|February 4, 2006
Regulation of the ClC-2 lung epithelial chloride channel by glycosylation of SP1Neeraj Vij, Pamela L Zeitlin
Pediatric Allergy, Immunology, and Pulmonology|August 5, 2022
Etiology of Bronchopulmonary Dysplasia: Before BirthPamela L Zeitlin, Lawrence M Nogee
Clinical Reviews in Allergy & Immunology|May 22, 2008
Atypical cystic fibrosis and CFTR-related diseasesShruti M Paranjape, Pamela L Zeitlin
Annals of the American Thoracic Society|June 16, 2021
Expanding CFTR Modulator Testing to Carriers of CFTR VariantsPreston E Bratcher, Pamela L Zeitlin
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging drug treatments for cystic fibrosisPamela L Zeitlin
The Journal of Clinical Investigation|November 27, 2008
Cystic fibrosis and estrogens: a perfect stormPamela L Zeitlin
Molecular Pharmacology|August 1, 2006
Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?Pamela L Zeitlin
American Journal of Physiology. Cell Physiology|June 26, 2009
Pseudomonas aeruginosa: can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa"Pamela L Zeitlin
Expert Opinion on Emerging Drugs|July 3, 2007
Emerging drug treatments for cystic fibrosisPamela L Zeitlin
Advanced Drug Delivery Reviews|November 30, 2002
Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targetingKristina Powell, Pamela L Zeitlin
American Journal of Respiratory Cell and Molecular Biology|February 4, 2006
Regulation of the ClC-2 lung epithelial chloride channel by glycosylation of SP1Neeraj Vij, Pamela L Zeitlin
Pediatric Allergy, Immunology, and Pulmonology|August 5, 2022
Etiology of Bronchopulmonary Dysplasia: Before BirthPamela L Zeitlin, Lawrence M Nogee
Clinical Reviews in Allergy & Immunology|May 22, 2008
Atypical cystic fibrosis and CFTR-related diseasesShruti M Paranjape, Pamela L Zeitlin
Annals of the American Thoracic Society|June 16, 2021
Expanding CFTR Modulator Testing to Carriers of CFTR VariantsPreston E Bratcher, Pamela L Zeitlin
Pageof 9